Cargando…
Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy
Immunotherapy has revolutionized care for many solid tissue malignancies, and is being investigated for efficacy in the treatment of malignant brain tumors. Identifying a non-invasive monitoring technique such as metabolomics monitoring to predict patient response to immunotherapy has the potential...
Autores principales: | Dastmalchi, Farhad, Deleyrolle, Loic P., Karachi, Aida, Mitchell, Duane A., Rahman, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209463/ https://www.ncbi.nlm.nih.gov/pubmed/34150663 http://dx.doi.org/10.3389/fonc.2021.691246 |
Ejemplares similares
-
The role of CMV in glioblastoma and implications for immunotherapeutic strategies
por: Rahman, Maryam, et al.
Publicado: (2018) -
Optimizing T Cell-Based Therapy for Glioblastoma
por: Karachi, Aida, et al.
Publicado: (2021) -
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling
por: Dastmalchi, Farhad, et al.
Publicado: (2019) -
Contemporary RNA Therapeutics for Glioblastoma
por: Melnick, Kaitlyn, et al.
Publicado: (2021) -
Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization
por: Silver, Aryeh, et al.
Publicado: (2022)